176 related articles for article (PubMed ID: 36152082)
1. SDC4-rs1981429 and ATM-rs228590 may provide early biomarkers of breast cancer risk.
Vuorinen SI; Okolicsanyi RK; Gyimesi M; Meyjes-Brown J; Saini D; Pham SH; Griffiths LR; Haupt LM
J Cancer Res Clin Oncol; 2023 Jul; 149(8):4563-4578. PubMed ID: 36152082
[TBL] [Abstract][Full Text] [Related]
2. Syndecan-4 regulates the HER2-positive breast cancer cell proliferation cells via CK19/AKT signalling.
Pham SH; Vuorinen SI; Arif KT; Griffiths LR; Okolicsanyi RK; Haupt LM
Biochimie; 2023 Apr; 207():49-61. PubMed ID: 36460206
[TBL] [Abstract][Full Text] [Related]
3. SDC4-rs1981429, ATM-rs228590 and biomarkers of breast cancer risk.
Mungmunpuntipantip R; Wiwanitkit V
J Cancer Res Clin Oncol; 2023 Apr; 149(4):1657. PubMed ID: 36335555
[TBL] [Abstract][Full Text] [Related]
4. Association of heparan sulfate proteoglycans SDC1 and SDC4 polymorphisms with breast cancer in an Australian Caucasian population.
Okolicsanyi RK; Buffiere A; Jacinto JM; Chacon-Cortes D; Chambers SK; Youl PH; Haupt LM; Griffiths LR
Tumour Biol; 2015 Mar; 36(3):1731-8. PubMed ID: 25361632
[TBL] [Abstract][Full Text] [Related]
5. Syndecan-1 and -4 influence Wnt signaling and cell migration in human breast cancers.
Pham SH; Pratt K; Okolicsanyi RK; Oikari LE; Yu C; Peall IW; Arif KT; Chalmers TA; Gyimesi M; Griffiths LR; Haupt LM
Biochimie; 2022 Jul; 198():60-75. PubMed ID: 35183674
[TBL] [Abstract][Full Text] [Related]
6. Oxidized ATM promotes abnormal proliferation of breast CAFs through maintaining intracellular redox homeostasis and activating the PI3K-AKT, MEK-ERK, and Wnt-β-catenin signaling pathways.
Tang S; Hou Y; Zhang H; Tu G; Yang L; Sun Y; Lang L; Tang X; Du YE; Zhou M; Yu T; Xu L; Wen S; Liu C; Liu M
Cell Cycle; 2015; 14(12):1908-24. PubMed ID: 25970706
[TBL] [Abstract][Full Text] [Related]
7. AKT is activated in an ataxia-telangiectasia and Rad3-related-dependent manner in response to temozolomide and confers protection against drug-induced cell growth inhibition.
Caporali S; Levati L; Starace G; Ragone G; Bonmassar E; Alvino E; D'Atri S
Mol Pharmacol; 2008 Jul; 74(1):173-83. PubMed ID: 18413665
[TBL] [Abstract][Full Text] [Related]
8. Cell surface heparan sulfate proteoglycans control adhesion and invasion of breast carcinoma cells.
Lim HC; Multhaupt HA; Couchman JR
Mol Cancer; 2015 Jan; 14(1):15. PubMed ID: 25623282
[TBL] [Abstract][Full Text] [Related]
9. MiR-18a-5p attenuates HER2-positive breast cancer development by regulating PI3K/AKT pathway.
Liu Y; Yang H
Cancer Biol Ther; 2023 Dec; 24(1):2224512. PubMed ID: 37394766
[TBL] [Abstract][Full Text] [Related]
10. MET inhibition enhances PARP inhibitor efficacy in castration-resistant prostate cancer by suppressing the ATM/ATR and PI3K/AKT pathways.
Zhou S; Dai Z; Wang L; Gao X; Yang L; Wang Z; Wang Q; Liu Z
J Cell Mol Med; 2021 Dec; 25(24):11157-11169. PubMed ID: 34761497
[TBL] [Abstract][Full Text] [Related]
11. An investigation of genetic polymorphisms in heparan sulfate proteoglycan core proteins and key modification enzymes in an Australian Caucasian multiple sclerosis population.
Okolicsanyi RK; Bluhm J; Miller C; Griffiths LR; Haupt LM
Hum Genomics; 2020 May; 14(1):18. PubMed ID: 32398079
[TBL] [Abstract][Full Text] [Related]
12. The phosphatidyl inositol 3-kinase/AKT signaling pathway in breast cancer.
Castaneda CA; Cortes-Funes H; Gomez HL; Ciruelos EM
Cancer Metastasis Rev; 2010 Dec; 29(4):751-9. PubMed ID: 20922461
[TBL] [Abstract][Full Text] [Related]
13. microRNA-140-3p modulates invasiveness, motility, and extracellular matrix adhesion of breast cancer cells by targeting syndecan-4.
Onyeisi JOS; Greve B; Espinoza-Sánchez NA; Kiesel L; Lopes CC; Götte M
J Cell Biochem; 2021 Oct; 122(10):1491-1505. PubMed ID: 34180077
[TBL] [Abstract][Full Text] [Related]
14. Cell surface proteoglycan syndecan-1 mediates hepatocyte growth factor binding and promotes Met signaling in multiple myeloma.
Derksen PW; Keehnen RM; Evers LM; van Oers MH; Spaargaren M; Pals ST
Blood; 2002 Feb; 99(4):1405-10. PubMed ID: 11830493
[TBL] [Abstract][Full Text] [Related]
15. Genetic variants in ATM, H2AFX and MRE11 genes and susceptibility to breast cancer in the polish population.
Podralska M; Ziółkowska-Suchanek I; Żurawek M; Dzikiewicz-Krawczyk A; Słomski R; Nowak J; Stembalska A; Pesz K; Mosor M
BMC Cancer; 2018 Apr; 18(1):452. PubMed ID: 29678143
[TBL] [Abstract][Full Text] [Related]
16. Gigantol inhibits proliferation and enhances DDP-induced apoptosis in breast-cancer cells by downregulating the PI3K/Akt/mTOR signaling pathway.
Huang J; Liu C; Duan S; Lin J; Luo Y; Tao S; Xing S; Zhang X; Du H; Wang H; Huang C; Wei G
Life Sci; 2021 Jun; 274():119354. PubMed ID: 33737087
[TBL] [Abstract][Full Text] [Related]
17. Regulation of natural cytotoxicity receptors by heparan sulfate proteoglycans in -cis: A lesson from NKp44.
Brusilovsky M; Radinsky O; Cohen L; Yossef R; Shemesh A; Braiman A; Mandelboim O; Campbell KS; Porgador A
Eur J Immunol; 2015 Apr; 45(4):1180-91. PubMed ID: 25546090
[TBL] [Abstract][Full Text] [Related]
18. NMR Structural Study of Syndecan-4 Transmembrane Domain with Cytoplasmic Region.
Kim M; Kim Y
Molecules; 2023 Nov; 28(23):. PubMed ID: 38067582
[TBL] [Abstract][Full Text] [Related]
19. Association of the SNP rs2623047 in the HSPG modification enzyme SULF1 with an Australian Caucasian breast cancer cohort.
Okolicsanyi RK; Faure M; Jacinto JM; Chacon-Cortes D; Chambers S; Youl PH; Haupt LM; Griffiths LR
Gene; 2014 Aug; 547(1):50-4. PubMed ID: 24911625
[TBL] [Abstract][Full Text] [Related]
20. Imatinib as a key inhibitor of the platelet-derived growth factor receptor mediated expression of cell surface heparan sulfate proteoglycans and functional properties of breast cancer cells.
Malavaki CJ; Roussidis AE; Gialeli C; Kletsas D; Tsegenidis T; Theocharis AD; Tzanakakis GN; Karamanos NK
FEBS J; 2013 May; 280(10):2477-89. PubMed ID: 23374223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
